Products for Research Use Only
RegisterLogin

ABBV-3373

CAT: 0804-HY-164894-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-164894-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ABBV-3373 is an anti-TNF antibody drug conjugate (ADC). ABBV-3373 is composed of the humanized antibody Adalimumab conjugated with a glucocorticoid receptor modulator (HY-148436). ABBV-3373 can be used in the study of rheumatoid arthritis[1].
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; Glucocorticoid Receptor; TNF Receptor
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Immunology/Inflammation; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/abbv-3373.html
Purity
98.78
Smiles
[ABBV-3373]
References & Citations
[1]Qu P, et al. Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate. J Med Chem. 2022 Dec 8;65 (23) :15893-15934.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Phase 2

Related Products

CatalogName
HY-116478-01L-3373
HY-142209-01ABBV-167
HY-112090-01ABBV-744
HY-146069-01ABBV-318
HY-156409-01ABBV-712
HY-149672-01ABBV-467
HY-170554-01ABBV-706
HY-111757ABBV-4083
HY-163827ABBV-992
HY-164893-01ABBV-154

Alternative Products

CatalogName
T9901A-446-01ABBV-3373
GTR18608288-01ABBV-3373 Antibody
PTX26323Anti-Human TNFa/TNF-alpha (ABBV-3373)
DHB94417Research Grade Anti-Human TNFa/TNF-alpha (ABBV-3373)
A136733Anti-TNFa/TNF-alpha (ABBV-3373) Biosimilar (Monoclonal, IgG)
T20134-01L-3373
BN179651-01NUC-3373
BA3354-5ABBV-467
BA1895-5ABBV-744
BA3349-1ABBV-167

Popular Products